February 4, 2022 -- Avidien has received a new financing round of $4 million from BroadOak Capital Partners. The investment will help Avidien expand its product road map, scale commercial production, and better serve research and pharmaceutical clients.
Avidien's flagship product, the microPro 300, provides precision semiautomated 96- and 384-channel pipetting to hundreds of biotech, medical testing, and research laboratories worldwide. The microPro 300 fills gaps in automation workflows by streamlining repetitive pipetting tasks and ensuring accurate, repeatable liquid transfers, according to Avidien.
BroadOak Capital Partners is a life sciences-focused financial institution. Avidien Technologies manufactures innovative and precision liquid handling solutions that are deployed in life science labs around the world.